NYLI Candriam U.S. Mid Cap Equity ETF
IQSM
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 51 Madison Avenue New York NY United States of America 10010
- IPO Date
- Oct 25, 2022
- Website
- newyorklifeinvestments.com
- Similar Companies
- Business
- NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that seeks investment results tracking the price and yield performance, before fees and expenses, of the NYLI Candriam U.S. Mid Cap Equity Index; the index provides exposure to U.S. mid-cap equity securities of companies satisfying Candriam's proprietary environmental, social, and governance (ESG) criteria. Launched on October 24, 2022, and managed by New York Life Investment Management LLC, a subsidiary of New York Life Insurance Company founded in 1845 and headquartered at 51 Madison Avenue in New York City, IQSM offers passive broad market exposure leveraging Candriam's industry-leading ESG research data; it features a low expense ratio of 0.15%, tax-sensitive structure, monthly distributions from net investment income, and diversified sector holdings primarily in the United States. The ETF targets investors seeking core equity holdings for income and capital appreciation potential across economic sectors, with assets under management exceeding $198 million as of recent data. Candriam, the index provider and a New York Life Investments affiliate founded in 1996 and headquartered in Luxembourg with offices in Brussels, Paris, London, and elsewhere, applies rigorous ESG screening to approximately 220 mid-cap stocks. In recent developments, New York Life Investments, overseeing approximately $725 billion in assets under supervision, has pursued strategic expansions including a minority stake acquisition in Kartesia for European private credit in late 2024, a planned 40% minority interest in Andera Partners to bolster its $65 billion global alternatives platform announced in September 2024, and a reported intention by Belfius to acquire a minority stake in Candriam by end-2025, enhancing multi-specialist offerings in equities, fixed income, and alternatives. These alliances complement IQSM's focus without direct fund-level changes, while effective August 31, 2025, the ETF adopted official closing price calculations for market price returns.